Journal Finder

Biotechnology Reports covers all aspects of Biotechnology particularly those reports that are useful and informative and that will be of value to other researchers in related fields. Biotechnology Reports loves ground breaking science, but will also accept good science that can be of use to the biotechnology community. The journal maintains a high quality peer review where submissions are considered on the basis of scientific validity and technical quality.

Acceptable paper types are research articles (short or full communications), methods, mini-reviews, and commentaries in the following areas:

• Healthcare and pharmaceutical biotechnology
• Agricultural and food biotechnology
• Environmental biotechnology
• Molecular biology, cell and tissue engineering and synthetic biology
• Industrial biotechnology, biofuels and bioenergy
• Nanobiotechnology
• Bioinformatics & systems biology
• New processes and products in biotechnology, bioprocess engineering

Biotechnology and Applied Biochemistry has been published continuously since its creation in 1986 (previous to that date it was called the Journal of Applied Biochemistry and was published from 1979 to 1985). Today it enjoys a superb track record, attracting distinguished authors from academia and industry from all over the world, reflecting its international status. Biotechnology and Applied Biochemistry is now published bi-monthly by Wiley-Blackwell, confirming the journal's dedication to change and commitment to rapid publication of high-quality, cutting-edge research at the interface between life sciences and their translation. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences. Promising advances in life sciences are leading to the identification of the molecular sources of disease and the creation of new generation of medicines for diseases for which there are currently either no therapies or inadequate treatments. Therapeutic proteins and antibodies are already having a significant impact in treatment of disease. Therapeutic genes and viruses promise to have an even bigger impact on human healthcare. DNA vaccine and gene-therapy are under intense development and new research areas such as tissue engineering, stem-cell therapeutics, germ-line therapy and regenerative medicines are expected to create a new wave of medicines that will make today's treatment of diseases look distinctively primitive. All this provides major challenges to life scientists and engineers engaged in discoveries and their translation to practical outcomes. Turning a new discovery into a successful application has become a highly integrated, multidisciplinary activity, and Biotechnology and Applied Biochemistry is uniquely placed to provide an international forum for the dissemination of information and discussion by researchers working across the many subject groups. The journal welcomes submissions of original articles on the following topics: nucleic acids and proteins engineering and purification; genes peptides and proteins therapy; biomaterials; biological modeling; stem cells and tissue engineering; bio-imaging; bio-sensors; biotechnology of food and natural compounds. Original papers and reviews as well as special issues can be also invited by the Editorial Board. Papers are easily submitted online at: http://mc.manuscriptcentral.com/bab.

Biotechnology & Bioengineering publishes Perspectives, Articles, Reviews, Mini-Reviews, and Communications to the Editor that embrace all aspects of biotechnology. These include:

Biotechnology and Bioprocess Engineering is an international bimonthly journal published by the Korean Society for Biotechnology and Bioengineering. Biotechnology and Bioprocess Engineering is devoted to the original and novel findings in the wide area of biotechnology and bioengineering which includes: Applied Biology, Biochemistry, Microbiology and Molecular Biology; Biomolecular Engineering, Biocatalysis & Biotransformation, and Metabolic Engineering; Bioseparation, Bioprocess Control and System Engineering; Nanobiotechnology, Biosensor and Bioelectronics, Cell Culture Engineering; Environmental Biotechnology; Food Biotechnology; Pharmaceutics; and Biomaterials.

Biotechnology for Biofuels is an open access, peer-reviewed online journal featuring high-quality studies describing technological and operational advances in the production of biofuels from biomass. 

Published since 1954, this monthly journal contains new research in the field of microbiology, including applied microbiology and biotechnology; microbial structure and function; fungi and other eucaryotic protists; infection and immunity; microbial ecology; physiology, metabolism and enzymology; and virology, genetics, and molecular biology. It also publishes review articles and notes on an occasional basis, contributed by recognized scientists worldwide.

Critical Reviews in Microbiology is an international, peer-reviewed journal that publishes comprehensive reviews covering all areas of microbiology, including molecular biology, microbial physiology, microbial pathogenicity, microbial biochemistry, microbial structure, medical microbiology, epidemiology, public health, and environmental microbiology. Of particular interest are reviews covering clinical aspects of the occurrence and treatment of bacterial, virological, fungal, and parasitic diseases; microbial genetics; and laboratory diagnosis. Reviews in food and industrial microbiology may also be considered. All reviews must be analytical, comprehensive, and balanced in nature. Editors welcome uninvited submissions, as well as suggested topics for reviews accompanied by an abstract.Read More: http://informahealthcare.com/page/mby/Description.

Cardiovascular imaging technologies now play an expanded role in clinical practice. Beyond the diagnosis of a disease process, these techniques are rapidly transitioning to help guide therapy. The journal aims to keep readers current with rapidly evolving advances in instrumentation and imaging procedures that support the expanded role of these technologies in clinical practice. The journal intends to place the entire area of cardiovascular imaging in its proper prospective by establishing the indications and limitations of each imaging technique and by summarizing recent clinical advances.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field, including cardiac magnetic resonance, nuclear imaging, echocardiography, cardiac computed tomography, intravascular, molecular, and hybrid imaging. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists.  An Editorial Board of internationally diverse members ensures that topics include emerging research and suggests topics of special interest to their country/region. We also provide commentaries from well-known figures in the field. 

Current Microbiology offers rapid publication of new research on all aspects of microbial cells including prokaryotes and eukaryotes and, where appropriate, viruses. The coverage spans general, medical, and applied microbiology and virology, drawing on physiology, biochemistry, genetics, biotechnology, morphology, taxonomy, diagnostic methods, and immunology as applied to microorganisms.

1. The views of experts on current advances in food science in a clear and readable form.
2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.

The subject of food science is divided into themed sections, each of which is reviewed once a year.

• Food Physics and Materials Science
• Food Engineering and Processing
• Food Toxicology
• Food Chemistry and Biochemistry
• Food Bioprocessing
• Food Microbiology
• Food Safety
• Food Mycology
• Sensory Sciences and Consumer Behavior
• Functional Foods and Nutrition
• Foodomics Technologies
• Innovations in Food Science

Reviews

Authors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.

Editorial Overview

Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.

Invited authors are encouraged to visit our Guide for Authors for information on article submission.

The journal provides an effective way to publish research and review articles, short communications and technical notes, Video material, animation sequences and 3D are also accepted to support and enhance articles. The articles will be examined by a scientific committee and anonymous evaluators and published every two months in HTML and PDF formats (January 15th , March 15th, May 15th, July 15th, September 15th, November 15th).

The following areas are covered in the Journal:
• Animal Biotechnology
• Bioethics
• Biofilms
• Bioinformatics
• Biopolicies of International Cooperation
• Biosafety
• Biotechnology Industry
• Biotechnology of Human Disorders
• Chemical Engineering
• Environmental Biotechnology
• Food Biotechnology
• Marine Biotechnology
• Medical Biotechnology
• Microbial Biotechnology
• Molecular Biology and Genetics
• Plant Biotechnology
• Process Biotechnology
• Process Chemistry and Technology

Electronic Journal of Biotechnology is a http://publicationethics.org/members/peerjfull Member of the Committee on Publication Ethics (http://publicationethics.org/COPE).

Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells.We especially encourage submissions on:Biocatalysis and the use of Directed Evolution in Synthetic Biology and BiotechnologyBiotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and BiofuelsNew Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems BiologyNew Biotechnological Approaches in Genomics, Proteomics and MetabolomicsMetabolic Engineering, Biomolecular Engineering and NanobiotechnologyManuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.

Journal of clinical and molecular medicine is a quarterly, peer-reviewed journal providing a platform for advances in health care/clinical practices in combination with basic findings in mechanisms of disease pathogenesis to therapy.

Cumulative of clinical practices with an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases is the primary goal of Journal.

Journal will feature research, review papers, reports, editorials, expert opinion and perspective papers, commentaries, and book reviews.

Journal of clinical and molecular medicine accepts direct submissions from authors: Attach your word file with e-mail and send it to: submissions@oatext.com  alternatively to editor.jcmm@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by Journal of clinical and molecular medicine, is properly cited.